Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Specific Ribotypes
Open Forum Infectious Diseases · 30.10.2024 · 11 (11)
DOI: 10.1093/ofid/ofae588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 10.10.2024. Verfasst von Taryn A Eubank und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, National Institutes of Health.
Abstract (Originalsprache)
Background
Reduced vancomycin (VAN) susceptibility in clinical Clostridioides difficile isolates is correlated with poor clinical outcomes. However, factors associated with infection with these strains are unknown. The goal of this study was to determine risk factors for reduced VAN susceptibility among clinical isolates of C. difficile.
Methods
This multicenter cohort study included adults with C. difficile infection (CDI) between 2016 and 2021. Clinical C. difficile isolates underwent agar dilution VAN susceptibility testing and ribotyping. Reduced susceptibility was defined as a minimum inhibitory concentration (MIC) > 2 µg/mL. Medical charts were reviewed for host, pathogen, and hospital characteristics and assessed for predictors of reduced VAN susceptibility.
Results
Five hundred and ninety-four hospitalized patients with CDI between 2016 and 2021 (female: 57%, age >65 years: 55%, White/non-Hispanic: 59%, nonsevere CDI episode: 53%) were identified. Of 594 isolates, 173 (29%) had reduced VAN susceptibility (MIC50: 2 µg/mL, MIC90: 4 µg/mL). In multivariable analysis, ribotype (RT) 027 (odds ratio [OR]: 13.4; 95% confidence interval [CI], 7.7–23.4; P < .0001) and RT 255 (OR: 2.9; 95% CI, 1.4–6.1; P = .005) were positively associated with reduced VAN susceptibility whereas RT 014–020 (OR: 0.41; 95% CI, 0.21–0.80; P = .0092) was more likely to be susceptible to VAN. The prevalence of strains with reduced VAN susceptibility increased over time (P = .0163). No patient- or hospitalization-specific variable predicted infection with reduced susceptibility strain.
Conclusions
Certain ribotypes, including RT 027, were the sole independent risk factors for reduced VAN susceptibility. Increased clinical surveillance of these strains, especially RT 027, and their antibiotic susceptibly is warranted to inform prescribing practices.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas, USA.
- Center of Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas, USA.
ORCID-Profile: Taryn A Eubank, Chetna Dureja, Anne J Gonzales-Luna, Julian G Hurdle, Kevin W Garey
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- American College of Clinical pharmacy Foundation Junior Investigator Research
- Society of Infectious Diseases Pharmacists Early Career Research
Zitieren
APA
Eubank, T. A., Dureja, C., Gonzales-Luna, A. J., Hurdle, J. G., & Garey, K. W. (2024). Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Specific Ribotypes. Open Forum Infectious Diseases, 11(11). https://doi.org/10.1093/ofid/ofae588
Vancouver
Eubank TA, Dureja C, Gonzales-Luna AJ, Hurdle JG, Garey KW. Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Specific Ribotypes. Open Forum Infectious Diseases. 2024;11(11). doi:10.1093/ofid/ofae588
BibTeX
@article{Eubank2024,
author = {Eubank, Taryn A and Dureja, Chetna and Gonzales-Luna, Anne J and Hurdle, Julian G and Garey, Kevin W},
title = {Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Specific Ribotypes},
journal = {Open Forum Infectious Diseases},
year = {2024},
volume = {11},
number = {11},
doi = {10.1093/ofid/ofae588}
}
EUVIMED